Fuwai Central China Cardiovascular Hospital
Zhengzhou, Henan, China
Location status: Recruiting
NCT Number: NCT07113769
Extracorporeal cardiopulmonary resuscitation (ECPR) constitutes a pivotal emergency intervention for cardiac arrest (CA) patients. However, current eligibility criteria and prognostic assessment metrics remain substantially limited, relying predominantly on clinical symptoms and physical signs while lacking objective biomarker data. Integrating reproducible, highly sensitive, and specific proteinaceous and metabolic indicators with ultrastructural platelet alterations may hold significant implications for both ECPR administration and prognostication in CA. Therefore, the purpose of this study is to identify the plasma proteomic and metabolomic characteristics of patients with refractory cardiac arrest before and after ECPR treatment, as well as the characteristics of platelet morphological and structural changes, to search for potential specific markers that can predict CA patients who may benefit from ECPR so as to optimize treatment selection.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Zhengzhou, Henan, China
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Within 30 days after ECPR
Time frame: Within 30 days after ECPR
Time frame: 30 days after ECPR
Cerebral Performance Category scale Range: 1 to 5 Interpretation: Lower scores indicate better neurological outcome (1 = good cerebral performance, 5 = brain death or severe vegetative state)
Time frame: Within 30 days after ECPR
Time frame: Within 30 days after ECPR
Time frame: Within 30 days after ECPR
Time frame: Within 30 days after ECPR
Contact information is provided by the study sponsor or research team.
Central China Fuwai Hospital of Zhengzhou University
Other
Explore Plasma Biomarkers and Platelet Morphological Signatures for Predicting Prognosis in Patients With Extracorporeal CardioPulmonary Resuscitation (ECPR) Using Multi-omics and Platelet Morphology Analysis
Acronym: ECPR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04601896
Cardiovascular Diseases, Extracorporeal Membrane Oxygenation (ECMO)
Grenoble, France
View Trial DetailsNCT07032987
Agnosia, Analgesia
London, United Kingdom
View Trial DetailsNCT06868823
Anticoagulants and Bleeding Disorders, Cardiovascular Diseases
Prague, Czech Republic, Czechia
View Trial DetailsNCT07709546
Extracorporeal Membrane Oxygenation (ECMO), Infections
View Trial Details